跳转至内容
Merck
CN

89270

胸苷

≥99.0% (HPLC), synthetic, powder

别名:

1-(2-脱氧-β-D-呋喃核糖)-5-甲基尿嘧啶, 1-(2-脱氧-β-D-呋喃核糖)胸苷, 2′-脱氧胸苷, dT, 胸腺嘧啶核苷

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C10H14N2O5
化学文摘社编号:
分子量:
242.23
NACRES:
NA.51
PubChem Substance ID:
UNSPSC Code:
41106305
EC Number:
200-070-4
MDL number:
Beilstein/REAXYS Number:
89285
Assay:
≥99.0% (HPLC)
Biological source:
synthetic
Form:
powder
Solubility:
hot water: 1 g/10 mL
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

胸苷, ≥99.0% (HPLC)

biological source

synthetic

Quality Level

assay

≥99.0% (HPLC)

form

powder

optical activity

[α]20/D +19±1°, c = 1% in H2O

mp

185-190 °C, 186-188 °C (lit.)

solubility

hot water: 1 g/10 mL

SMILES string

CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O

InChI

1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1

InChI key

IQFYYKKMVGJFEH-XLPZGREQSA-N

Application

胸腺嘧啶已用于:
  • 培养人成纤维细胞系。
  • 体外伤口愈合试验。
  • 培养各种癌症细胞系。


Still not finding the right product?

Explore all of our products under 胸苷


存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Cédric F Invernizzi et al.
The Journal of antimicrobial chemotherapy, 68(10), 2192-2196 (2013-06-12)
We recently reported the preferential selection of the K65R resistance mutation in subtype C HIV-1 compared with subtype B and showed the underlying mechanism to be dependent on subtype C-specific silent nucleotide polymorphisms, i.e. genomic mutations that change the genotype
Yee Suan Poo et al.
PLoS neglected tropical diseases, 8(12), e3354-e3354 (2014-12-05)
The recent epidemic of the arthritogenic alphavirus, chikungunya virus (CHIKV) has prompted a quest to understand the correlates of protection against virus and disease in order to inform development of new interventions. Herein we highlight the propensity of CHIKV infections
Anne P Bouvy et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 29(8), 1587-1597 (2014-04-29)
To evaluate the influence of induction therapy on Tregs we investigated their origin, kinetics and function in kidney transplant patients after treatment with T-cell depleting rabbit antithymocyte globulin (rATG) or IL-2 receptor antagonist basiliximab. Flow cytometry was used to study



全球贸易项目编号

货号GTIN
89270-1G04061833075685
89270-25G04061833416082
89270-5G04061833075692